Considering the ceo's last company turned out to be worth 30-40m from nothing it is just a matter of time for this one. If it was a pharma company like in the states it would jump 30-40% on good news but since it's on the asx it takes a lot more to even budge a stocks price. Sales of the product need to increase a lot also then as mentioned above some bigger investors may start to take notice.
